Gal-8, formerly called prostate cancer tumor antigen-1, or PCTA-1, is strongly expressed during all stages of the disease; its high and constant expression is indispensable for metastatic properties of prostate tumor cells [43]. Here, LGALS8 is linked to prostate neoplasm.